BPA Call HT942523A0001-HT009024FG0310009
Award Date 3/6/24
Potential Completion Date 9/30/24
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Round Rock, TX 78665, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price contract award to Cerilliant Corporation, a foreign-owned for-profit manufacturer, is for the provision of drug standards that will be used for screening and testing of service members' specimens. The contract, valued at $12,538.24, was awarded by the Defense Health Agency on March 26, 2024, with a completion date of September 30, 2024. This appears to be a call under a larger Blanket Purchase Agreement (BPA) vehicle, as the contract type is listed as "BPA...
- This federal contract award to Cerilliant Corporation, a foreign-owned manufacturer based in Round Rock, Texas, is for the supply of drug standards used for screening and confirmation testing of urine, blood, and tissue samples from service members suspected of drug use. The $10,010.88 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), a defense agency. Cerilliant, which has over 30 years of experience as a government contractor, will...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $15,562.95 to Cerilliant Corporation for drug reference standards. This firm fixed-price call, issued October 1, 2023, with completion by June 6, 2025, supports the Defense Health Agency's drug testing and forensic toxicology operations at Fort Meade, Maryland. Cerilliant Corporation, a foreign-owned manufacturer headquartered in Round Rock, Texas, specializes in certified reference materials and chemical...
- This firm fixed price contract was awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a foreign-owned, for-profit manufacturer located in Round Rock, Texas. The contract, valued at $10,317.66, is for the provision of drug standards needed for screening and testing of service member specimens. The contract is a blanket purchase agreement (BPA) call and does not have a set-aside designation. Cerilliant is a longtime provider of certified reference standards and materials to...
- This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
- The Defense Health Agency awarded a $21,685.45 firm fixed price Blank Purchase Agreement (BPA) call to Cerilliant Corporation for drug standards to be used in screening and analysis testing for suspected drug use in service member blood, urine, and/or tissue testing. This contract, which was not issued under any set-aside designation, leverages Cerilliant's established Indefinite Delivery Vehicle with the Defense Health Agency—a $250,000 BPA for drug reference standards and laboratory supplies...
- Cerilliant Corporation was awarded a $13,064.06 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide laboratory supplies. The contract has no set-aside designation and runs from the May 19, 2023 award date through the May 19, 2023 completion date. Cerilliant will deliver the requested chemical and biological reference standards and calibrators to support the agency's laboratory programs from their place of performance in Fort Meade, Maryland. No...
- Cerilliant Corporation, doing business as Cerilliant API Services LLC, was awarded a Blanket Purchase Agreement (BPA) call valued at $15,522.70 by the Defense Health Agency on August 1, 2024, with an ultimate completion date of August 15, 2024. This Firm Fixed Price contract, designated FTDTL BPA CALL W91YTZ23A0014, will be performed at Fort Meade, Maryland, and involves the supply of certified reference materials and laboratory supplies. The award carries no set-aside designation, reflecting...
- Cerilliant Corporation was awarded a firm fixed price call against the Blanket Purchase Agreement with the Defense Health Agency with a potential value of $19,158.95. The contract is for the provision of reference standards, reagents, calibrators and other laboratory materials to support testing and healthcare programs at Fort Meade, Maryland. No set aside designation was applied. Cerilliant is a global leader in supplying chemical and biological reference standards to federal agencies. They...
- Cerilliant Corporation was awarded a $19,723.40 firm fixed price blanket purchase agreement call from the Defense Health Agency to provide drug supplies. As a global leader in certified reference standards for over 30 years, Cerilliant will deliver chemical reference materials from its Round Rock, Texas headquarters to support agency testing and healthcare programs at the place of performance in Fort Meade, Maryland. Cerilliant currently holds several indefinite delivery/indefinite quantity...